版本:
中国

BRIEF-Pfizer reports positive top-line results from reflections B537-02 study for PF-06438179

Sept 16 Pfizer Inc :

* Results confirm similar efficacy of PF-06438179 (Infliximab-pfizer) to Remicade(REG) (Infliximab), in combination with Methotrexate

* Line results from reflections B537-02 study for PF-06438179 (Infliximab-Pfizer) a potential biosimilar to Remicade (Infliximab)

* Confirmatory study of PF-06438179 met its primary endpoint Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐